How home infusion improves RA treatment adherence and saves employers millions

Rheumatoid arthritis (RA) isn’t just painful. It’s progressive. Missing even a single infusion can lead to joint damage, increased pain and irreversible disability. Yet many RA patients struggle to stay on track with treatment due to:

• Long travel times and wait times at hospitals or infusion centers
• Scheduling difficulties—appointments are often booked out weeks or months in advance
• Financial stress—high out-of-pocket costs from facility fees and markups
• Work disruptions—taking four hours per infusion on average
• Fatigue and mobility challenges, making travel especially difficult

The reality? Missed or delayed infusions contribute to 50% of treatment failures.

The result? Increased pain, disease progression, ER visits, and long-term disability claims.

Miss our last post on managing the high cost of RA infusion? Read it here.

The high cost of non-adherence for employers

Skipping or delaying infusions isn’t just a health issue, it’s a major cost driver for employers:

• RA patients miss 10 additional workdays per year due to treatment delays, flares, or hospitalizations.
• RA-related absenteeism costs employers over $250 million annually.
• RA is a leading cause of disability claims—with short-term disability averaging $6,900 per employee, and 19% of claims transitioning to long-term disability.

Every delayed infusion increases the risk of: 

• Emergency room visits
• Expensive hospital stays
• Long-term joint damage, forcing early workforce exits

Home infusion: The adherence game-changer

Leap eliminates the biggest barriers to adherence by bringing treatment directly to patients, helping them stay on schedule and stay healthy.

Here’s how home infusion directly improves adherence for RA patients:

• Eliminates travel time: infusions happen at home, on the patient’s schedule
• Reduces missed workdays: patients save hours per treatment
• Lowers costs: transparent pricing removes unnecessary markups and surprise bills
• Improves patient satisfaction: 98% of Leap Health patients report high satisfaction

With better adherence, RA patients experience fewer flares, fewer hospitalizations, and better long-term outcomes.

The savings for employers

• RA patients have an average healthcare expenditure of up to $24,069 annually 
• Leap Health saves employers an average of $24,000 per RA patient per year
• Reducing disability claims alone could save companies millions annually

It’s simple: Better adherence = lower costs, healthier employees, and a stronger workforce.

Time to rethink RA infusion care

The traditional hospital-based model is failing RA patients, and driving up costs for employers. Home infusion solves both problems.

Learn how Leap is transforming RA treatment adherence and saving employers millions today.